×
About 9,468 results

ALLMedicine™ Aspergillosis Center

Research & Reviews  4,459 results

Primary aspergillosis of the larynx causing acute airway distress.
https://doi.org/10.1136/bcr-2020-240434
BMJ Case Reports; Ranford D, Kang C et. al.

Apr 10th, 2021 - Laryngeal aspergillosis is most commonly seen as a secondary infection that spreads from the lungs and tracheobronchial tree. Primary invasive aspergillosis of the larynx is rare and most likely seen in an immunocompromised patient. We present a c...

Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum gal...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036023
Medicine Dai Z, Cai M et. al.

Apr 9th, 2021 - The incidence of invasive pulmonary aspergillosis (IPA) is increasing higher in non-neutropenic patients. This study aimed to assess the diagnostic performance of bronchoalveolar lavage fluid (BALF). Galactomannan (GM), serum GM, and 1,3-β-d-gluca...

Prognostic factors of chronic pulmonary aspergillosis: A retrospective cohort of 264 pa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016288
PloS One; Kimura Y, Sasaki Y et. al.

Apr 1st, 2021 - Chronic pulmonary aspergillosis (CPA) develops in various underlying pulmonary conditions. There is scarce data evaluating interstitial lung disease (ILD)/abnormalities (ILA) as such conditions, and it has not been explored much whether non-tuberc...

Voriconazole Sequestration During Extracorporeal Membrane Oxygenation for Invasive Lung...
https://doi.org/10.1097/MAT.0000000000001427
ASAIO Journal (American Society for Artificial Internal O... Mathieu A, Thiboutot Z et. al.

Mar 31st, 2021 - The increasing use of extracorporeal membrane oxygenation (ECMO) in critical care introduces new challenges with medication dosing. Voriconazole, a commonly used antifungal and the first-choice agent for the treatment of invasive aspergillosis, is...

Misdiagnosis of chronic pulmonary aspergillosis as pulmonary tuberculosis at a tertiary...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007227
Journal of Medical Case Reports; Kwizera R, Katende A et. al.

Mar 30th, 2021 - Diagnosis of chronic pulmonary aspergillosis (CPA) is based on a combination of clinical symptomatology, compatible chest imaging findings, evidence of Aspergillus infection and exclusion of alternative diagnosis, all occurring for more than 3 mon...

see more →

Guidelines  17 results

Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727169
American Journal of Respiratory and Critical Care Medicine; Hage CA, Carmona EM et. al.

Aug 30th, 2019 - Background: Fungal infections are of increasing incidence and importance in immunocompromised and immunocompetent patients. Timely diagnosis relies on appropriate use of laboratory testing in susceptible patients.Methods: The relevant literature r...

ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates a...
https://doi.org/10.1016/j.cmi.2019.05.019
Clinical Microbiology and Infection : the Official Public... Warris A, Lehrnbecher T et. al.

Jun 3rd, 2019 - Presenting symptoms, distributions and patterns of diseases and vulnerability to invasive aspergillosis (IA) are similar between children and adults. However, differences exist in the epidemiology and underlying conditions, the usefulness of newer...

Information for Healthcare Professionals about Aspergillosis
https://www.cdc.gov/fungal/diseases/aspergillosis/health-professionals.html

Dec 31st, 2018 - Information for healthcare professionals about aspergillosis. Aspergillosis is a disease caused by Aspergillus, a common mold (a type of fungus) that lives indoors and outdoors. Most people breathe in Aspergillus spores every day without getting s...

Individualized Medication of Voriconazole: A Practice Guideline of the Division of Ther...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250289
Therapeutic Drug Monitoring; Chen K, Zhang X et. al.

Sep 7th, 2018 - Voriconazole (VRZ) is a second-generation triazole antifungal agent with broad-spectrum activity. It is available in both intravenous and oral formulations, and is primarily indicated for treating invasive aspergillosis. The most commonly used dos...

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-...
https://doi.org/10.1016/j.cmi.2018.01.002
Clinical Microbiology and Infection : the Official Public... Ullmann AJ, Aguado JM et. al.

Mar 16th, 2018 - The European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory Society Joint Clinical Guidelines focus on diagnosis and management of aspergillosis. Of the numero...

see more →

Drugs  161 results see all →

Clinicaltrials.gov  4,705 results

Primary aspergillosis of the larynx causing acute airway distress.
https://doi.org/10.1136/bcr-2020-240434
BMJ Case Reports; Ranford D, Kang C et. al.

Apr 10th, 2021 - Laryngeal aspergillosis is most commonly seen as a secondary infection that spreads from the lungs and tracheobronchial tree. Primary invasive aspergillosis of the larynx is rare and most likely seen in an immunocompromised patient. We present a c...

Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum gal...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036023
Medicine Dai Z, Cai M et. al.

Apr 9th, 2021 - The incidence of invasive pulmonary aspergillosis (IPA) is increasing higher in non-neutropenic patients. This study aimed to assess the diagnostic performance of bronchoalveolar lavage fluid (BALF). Galactomannan (GM), serum GM, and 1,3-β-d-gluca...

Prognostic factors of chronic pulmonary aspergillosis: A retrospective cohort of 264 pa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016288
PloS One; Kimura Y, Sasaki Y et. al.

Apr 1st, 2021 - Chronic pulmonary aspergillosis (CPA) develops in various underlying pulmonary conditions. There is scarce data evaluating interstitial lung disease (ILD)/abnormalities (ILA) as such conditions, and it has not been explored much whether non-tuberc...

Voriconazole Sequestration During Extracorporeal Membrane Oxygenation for Invasive Lung...
https://doi.org/10.1097/MAT.0000000000001427
ASAIO Journal (American Society for Artificial Internal O... Mathieu A, Thiboutot Z et. al.

Mar 31st, 2021 - The increasing use of extracorporeal membrane oxygenation (ECMO) in critical care introduces new challenges with medication dosing. Voriconazole, a commonly used antifungal and the first-choice agent for the treatment of invasive aspergillosis, is...

Misdiagnosis of chronic pulmonary aspergillosis as pulmonary tuberculosis at a tertiary...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007227
Journal of Medical Case Reports; Kwizera R, Katende A et. al.

Mar 30th, 2021 - Diagnosis of chronic pulmonary aspergillosis (CPA) is based on a combination of clinical symptomatology, compatible chest imaging findings, evidence of Aspergillus infection and exclusion of alternative diagnosis, all occurring for more than 3 mon...

see more →

News  117 results

Doctors Search for Missing Link Between COVID and ITP
https://www.medscape.com/viewarticle/944801

Jan 26th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hospitalist Sarah Stone, MD, arrived for her dayshift at Sharp Chula Vista in California one day in late December. The ICU and hospital wards were...

The COVID Complication You Might Miss
https://www.medscape.com/viewarticle/940740_2

Nov 18th, 2020 - COVID-Associated Pulmonary Aspergillosis (CAPA)   CAPA is a recently recognized complication of COVID-19. Although aspergillosis is classically associated with severely immunocompromised patients, it is increasingly detected in patients who receiv...

Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man
https://www.mdedge.com/fedprac/article/171981/hematology/fatal-drug-resistant-invasive-pulmonary-aspergillus-fumigatus-56/page/0/2?channel=327

Aug 14th, 2019 - Conclusion This fatal case of invasive pulmonary aspergillosis illustrates the importance of considering the 4 main causes of treatment failure in an infection. Although the patient had a high burden of disease with a rare resistance pattern, he w.

Fast Five Quiz: How Much Do You Know About Asthma?
https://reference.medscape.com/viewarticle/846001_4

Jun 3rd, 2019 - Blood eosinophilia > 4% or 300-400 cells/μL supports the diagnosis of asthma, but the absence of this finding is not exclusionary. Total serum immunoglobulin E levels > 100 IU/mL are frequently observed in patients experiencing allergic reactions,...

Disseminated invasive aspergillosis in an immunocompetent patient
https://www.mdedge.com/ccjm/article/201706/infectious-diseases/disseminated-invasive-aspergillosis-immunocompetent-patient?channel=162
Jessica McLaughlin, DO, Eric Libre, MD, FCCP et. al.

Jun 3rd, 2019 - A 57-year-old woman was admitted to our hospital for progressive hypoxic respiratory failure that developed after 10 days of empiric treatment at another hospital for an exacerbation of chronic obstructive pulmonary disease (COPD). Figure 1.

see more →

Patient Education  9 results see all →